Legis Daily

Medicaid PARTNERSHIP Act

USA115th CongressHR-5801| House 
| Updated: 6/20/2018
H. Morgan Griffith

H. Morgan Griffith

Republican Representative

Virginia

Cosponsors (3)
Marsha Blackburn (Republican)Greg Walden (Republican)Brian K. Fitzpatrick (Republican)

Finance Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicaid Providers Are Required To Note Experiences in Record Systems to Help In-need Patients Act or the Medicaid PARTNERSHIP Act (Sec. 2) This bill requires each state to: (1) establish a prescription drug monitoring program (PDMP), and (2) require health care providers to check the PDMP for a Medicaid enrollee's prescription drug history before prescribing controlled substances to the enrollee. In addition to meeting other specified requirements, each PDMP must allow health care providers to access the number and type of controlled substances prescribed to a Medicaid enrollee during the most recent 12-month period. The bill also temporarily increases the federal matching rate with respect to Medicaid expenditures related to PDMP implementation for states that have agreements to promote PDMP interoperability with their neighboring states. The Centers for Medicare & Medicaid Services must publish guidance and best practices for states regarding PDMP utilization. Additionally, the Government Accountability Office must report on PDMP administration.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 560.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-725.
Jun 19, 2018
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5245-5247)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5801.
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5245-5247)
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5245-5247)
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
  • May 15, 2018
    Introduced in House


  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.


  • May 17, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • May 17, 2018
    Committee Consideration and Mark-up Session Held.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 560.


  • June 12, 2018
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-725.


  • June 19, 2018
    Mr. Guthrie moved to suspend the rules and pass the bill, as amended.


  • June 19, 2018
    Considered under suspension of the rules. (consideration: CR H5245-5247)


  • June 19, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 5801.


  • June 19, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5245-5247)


  • June 19, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5245-5247)


  • June 19, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 20, 2018
    Received in the Senate and Read twice and referred to the Committee on Finance.

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth information and medical recordsHealth programs administration and fundingIntergovernmental relationsMedicaidPrescription drugsRight of privacyState and local government operations

Medicaid PARTNERSHIP Act

USA115th CongressHR-5801| House 
| Updated: 6/20/2018
Medicaid Providers Are Required To Note Experiences in Record Systems to Help In-need Patients Act or the Medicaid PARTNERSHIP Act (Sec. 2) This bill requires each state to: (1) establish a prescription drug monitoring program (PDMP), and (2) require health care providers to check the PDMP for a Medicaid enrollee's prescription drug history before prescribing controlled substances to the enrollee. In addition to meeting other specified requirements, each PDMP must allow health care providers to access the number and type of controlled substances prescribed to a Medicaid enrollee during the most recent 12-month period. The bill also temporarily increases the federal matching rate with respect to Medicaid expenditures related to PDMP implementation for states that have agreements to promote PDMP interoperability with their neighboring states. The Centers for Medicare & Medicaid Services must publish guidance and best practices for states regarding PDMP utilization. Additionally, the Government Accountability Office must report on PDMP administration.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 560.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-725.
Jun 19, 2018
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5245-5247)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5801.
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5245-5247)
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5245-5247)
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
  • May 15, 2018
    Introduced in House


  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.


  • May 17, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • May 17, 2018
    Committee Consideration and Mark-up Session Held.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 560.


  • June 12, 2018
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-725.


  • June 19, 2018
    Mr. Guthrie moved to suspend the rules and pass the bill, as amended.


  • June 19, 2018
    Considered under suspension of the rules. (consideration: CR H5245-5247)


  • June 19, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 5801.


  • June 19, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5245-5247)


  • June 19, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5245-5247)


  • June 19, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 20, 2018
    Received in the Senate and Read twice and referred to the Committee on Finance.
H. Morgan Griffith

H. Morgan Griffith

Republican Representative

Virginia

Cosponsors (3)
Marsha Blackburn (Republican)Greg Walden (Republican)Brian K. Fitzpatrick (Republican)

Finance Committee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth information and medical recordsHealth programs administration and fundingIntergovernmental relationsMedicaidPrescription drugsRight of privacyState and local government operations